These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20068572)

  • 1. Myelodysplastic syndromes: lost between two states?
    Acquaviva C; Gelsi-Boyer V; Birnbaum D
    Leukemia; 2010 Jan; 24(1):1-5. PubMed ID: 20068572
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic and chromosomal abnormalities in myelodysplastic syndrome].
    Mitani K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():108-12. PubMed ID: 23133937
    [No Abstract]   [Full Text] [Related]  

  • 3. [An update on epigenetic regulator gene mutations and pathogenesis of myelodysplastic syndromes].
    Wang JY; Xiao ZJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1303-9. PubMed ID: 22040993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of acquired aplastic anemia by targeted sequencing.
    Heuser M; Schlarmann C; Dobbernack V; Panagiota V; Wiehlmann L; Walter C; Beier F; Ziegler P; Yun H; Kade S; Kirchner A; Huang L; Koenecke C; Eder M; Brümmendorf TH; Dugas M; Ganser A; Thol F
    Haematologica; 2014 Sep; 99(9):e165-7. PubMed ID: 24907358
    [No Abstract]   [Full Text] [Related]  

  • 5. Alteration of cohesin genes in myeloid diseases.
    Rocquain J; Gelsi-Boyer V; Adélaïde J; Murati A; Carbuccia N; Vey N; Birnbaum D; Mozziconacci MJ; Chaffanet M
    Am J Hematol; 2010 Sep; 85(9):717-9. PubMed ID: 20687102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
    Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
    Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts.
    Mauvieux L; Helias C; Perrusson N; Lioure B; Sorel N; Brizard F; Lessard M
    Leukemia; 2004 Aug; 18(8):1436-8. PubMed ID: 15175627
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Abuhadra N; Mukherjee S; Al-Issa K; Adema V; Hirsch CM; Advani A; Przychodzen B; Makhoul A; Awada H; Maciejewski JP; Sekeres MA; Nazha A
    Leuk Lymphoma; 2019 Jun; 60(6):1587-1590. PubMed ID: 30618304
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of clonal dynamics and differential response to targeted therapy in a case of systemic mastocytosis with associated myelodysplastic syndrome.
    Yun HD; Antony ML; Linden MA; Noble-Orcutt KE; Eckfeldt CE; Ustun C; Nelson AC; Sachs Z
    Leuk Res; 2020 Aug; 95():106404. PubMed ID: 32569927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analyses of the mutations of AML 1 gene in myelodysplastic syndromes].
    Yoichi I
    Rinsho Ketsueki; 2002 Mar; 43(3):139-45. PubMed ID: 11979742
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
    Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
    Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEL and MN1 fusion in myelodysplastic syndrome: new evidence for a therapy-related event.
    Vieira L; Marques B; Ambrósio AP; Chumbo M; Reis AB; Júnior EC; Boavida MG
    Br J Haematol; 2000 Jul; 110(1):238-9. PubMed ID: 10931009
    [No Abstract]   [Full Text] [Related]  

  • 13. An atypical myelodysplastic syndrome with t(9;12)(q22;p12) and TEL gene rearrangement.
    Kuno Y; Abe A; Emi N; Iida M; Yamamori T; Tanimoto M; Saito H
    Br J Haematol; 1999 Aug; 106(2):570-1. PubMed ID: 10460625
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of JAK2 and TET2 mutations in myelodysplastic syndromes.
    Hellström-Lindberg E
    Blood Rev; 2010 Mar; 24(2):83-90. PubMed ID: 20171768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of CUTL1 in childhood myeloid neoplasias with monosomy 7.
    Hindersin S; Niemeyer CM; Germing U; Göbel U; Kratz CP
    Leuk Res; 2007 Sep; 31(9):1323-4. PubMed ID: 17140660
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
    Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U
    Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Any role for the nucleophosmin (NPM1) gene in myelodysplastic syndromes and acute myeloid leukemia with chromosome 5 abnormalities?
    Falini B
    Leuk Lymphoma; 2007 Nov; 48(11):2093-5. PubMed ID: 17990174
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutation in TET2 in myeloid cancers.
    Tefferi A; Lim KH; Levine R
    N Engl J Med; 2009 Sep; 361(11):1117; author reply 1117-8. PubMed ID: 19741235
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
    Voso MT; Fabiani E; Piciocchi A; Matteucci C; Brandimarte L; Finelli C; Pogliani E; Angelucci E; Fioritoni G; Musto P; Greco M; Criscuolo M; Fianchi L; Vignetti M; Santini V; Hohaus S; Mecucci C; Leone G
    Leukemia; 2011 Dec; 25(12):1910-3. PubMed ID: 21760590
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of atypical myelodysplastic syndrome with a novel reciprocal translocation t(1;12)(q21;p13).
    Sánchez J; Serrano J; Román J; García JM; Nomdedéu J; Torres A
    Haematologica; 2000 Apr; 85(4):434-5. PubMed ID: 10756375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.